5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience

被引:32
作者
Chan, Danny Tat Ming [1 ]
Sonia, Hsieh Yi-Pin [1 ]
Poon, Wai Sang [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, CUHK Otto Wong Brain Tumor Ctr, Hong Kong, Hong Kong, Peoples R China
关键词
5-Aminolevulinic acid; Malignant glioma; Fluorescence guided surgery; Protophophrin IX; Extent of resection; ADJUVANT TEMOZOLOMIDE; PHASE-III; GLIOBLASTOMA; RADIOTHERAPY; TRIAL; CONCOMITANT; SURVIVAL; SURGERY;
D O I
10.1016/j.asjsur.2017.06.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: 5-Aminolevulinic Acid (5-ALA) induced fluorescence is useful in guiding glioma resection. The extent of 5-ALA accumulation is beyond gadolinium contrast enhancement. (1,2)Supratotal resection may be achieved, potentially granting patients with better survival. We present our experience on 5-ALA guided glioma resection in Chinese ethnics. Method: Sixteen Patients ingested 5-ALA (Gliolan, Medas Germany) 20 mg/kg.m(2) 4 h before surgery. The tumor resection was guided by fluorescence with neurosurgical microscope. Patient was monitored for general condition, especially for new neurological deficits. Postoperative MRI served as the assessment for extent of resection (EOR). Result: High grade glioma was confirmed in 12 cases, low grade glioma in three and one inflammation. 5-ALA was used in ten patients with known malignant glioma, and in six patients with presumed diagnosis of malignant glioma. Fifteen cases had positive fluorescence. The intensity was strong in eight and moderate in seven cases. MRI suggested total resection was achieved in 9 patients, near total resection in two and five had subtotal resection. EOR was associated with duration between ingestion of 5-ALA and timing when microscope was brought in for visualization of fluorescence (p = 0.038). Two patients suffered from temporary visual field defects. One patient developed hemiparesis after surgery. Conclusion: 5-ALA is a useful intra-operative guidance for resection. It increases the percentage of total removal of the tumor. It should be used within the window period of the action (4-12 h). (C) 2017 Asian Surgical Association and Taiwan Robotic Surgical Association. Publishing services by Elsevier B.V.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 17 条
  • [1] [Anonymous], 2007, SCI DISCUSSION 5 ALA
  • [2] Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma
    Chang, Eric L.
    Akyurek, Serap
    Avalos, Tedde
    Rebueno, Neal
    Spicer, Chris
    Garcia, John
    Famiglietti, Robin
    Allen, Pamela K.
    Chao, K. S. Clifford
    Mahajan, Anita
    Woo, Shiao Y.
    Maor, Moshe H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 144 - 150
  • [3] Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment
    Coburger, Jan
    Engelke, Jens
    Scheuerle, Angelika
    Thal, Dietmar R.
    Hlavac, Michal
    Wirtz, Christian Rainer
    Koenig, Ralph
    [J]. NEUROSURGICAL FOCUS, 2014, 36 (02)
  • [4] Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: Theoretical, biochemical and practical aspects
    Colditz, Michael J.
    van Leyen, Karin
    Jeffree, Rosalind L.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (12) : 1611 - 1616
  • [5] Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience
    Diez Valle, Ricardo
    Tejada Solis, Sonia
    Idoate Gastearena, Miguel Angel
    Garcia de Eulate, Reyes
    Dominguez Echavarri, Pablo
    Aristu Mendiroz, Javier
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (01) : 105 - 113
  • [6] Gliolan, 2010, INN 5 AM AC HYDR
  • [7] A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas
    Lau, Darryl
    Hervey-Jumper, Shawn L.
    Chang, Susan
    Molinaro, Annette M.
    McDermott, Michael W.
    Phillips, Joanna J.
    Berger, Mitchel S.
    [J]. JOURNAL OF NEUROSURGERY, 2016, 124 (05) : 1300 - 1309
  • [8] Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters Clinical article
    Roberts, David W.
    Valdes, Pablo A.
    Harris, Brent T.
    Fontaine, Kathryn M.
    Hartov, Alexander
    Fan, Xiaoyao
    Ji, Songbai
    Lollis, S. Scott
    Pogue, Brian W.
    Leblond, Frederic
    Tosteson, Tor D.
    Wilson, Brian C.
    Paulsen, Keith D.
    [J]. JOURNAL OF NEUROSURGERY, 2011, 114 (03) : 595 - 603
  • [9] An extent of resection threshold for newly diagnosed glioblastomas
    Sanai, Nader
    Polley, Mei-Yin
    McDermott, Michael W.
    Parsa, Andrew T.
    Berger, Mitchel S.
    [J]. JOURNAL OF NEUROSURGERY, 2011, 115 (01) : 3 - 8
  • [10] Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
    Stummer, W
    Pichlmeier, U
    Meinel, T
    Wiestler, OD
    Zanella, F
    Hans-Jurgen, R
    [J]. LANCET ONCOLOGY, 2006, 7 (05) : 392 - 401